These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 10321365)

  • 1. The importance of age in screening for cancer.
    Law MR; Morris JK; Wald NJ
    J Med Screen; 1999; 6(1):16-20. PubMed ID: 10321365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
    Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
    Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
    Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
    Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer screening in the primary care setting: the role of the primary care physician in screening for breast, cervical, colorectal, lung, ovarian, and prostate cancers.
    Miser WF
    Prim Care; 2007 Mar; 34(1):137-67. PubMed ID: 17481991
    [No Abstract]   [Full Text] [Related]  

  • 6. [Screening for cancer. International knowledge and Danish practice].
    Lynge E
    Ugeskr Laeger; 2002 May; 164(22):2892-7. PubMed ID: 12082817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer: incidence and deaths in Canada, 1990.
    Gaudette L; Lee J; Silberberger C
    Health Rep; 1993; 5(4):348-54. PubMed ID: 8011953
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer screening rates in individuals with different life expectancies.
    Royce TJ; Hendrix LH; Stokes WA; Allen IM; Chen RC
    JAMA Intern Med; 2014 Oct; 174(10):1558-65. PubMed ID: 25133746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of cancer in the United States.
    Cresanta JL
    Prim Care; 1992 Sep; 19(3):419-41. PubMed ID: 1410056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of screening in women cancers and in 75 years older in Loire department].
    Swalduz A; Guibert C; Trone JC; Guichard JB; Rivoirard R; Pacaut C; Méry B; Guy JB; Eddekkaoui H; Fournel P; de Laroche G; Merrouche Y; Magné N
    Bull Cancer; 2014 Sep; 101(9):808-12. PubMed ID: 25229392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal, cervical and prostate cancer screening in Australians with severe mental illness: Retrospective nation-wide cohort study.
    Tuesley KM; Jordan SJ; Siskind DJ; Kendall BJ; Kisely S
    Aust N Z J Psychiatry; 2019 Jun; 53(6):550-558. PubMed ID: 30501394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some interpretation of regional estimates of the incidence of cancer in France over the period 1980--2005].
    Colonna M; Bossard N; Mitton N; Remontet L; Belot A; Delafosse P; Grosclaude P;
    Rev Epidemiol Sante Publique; 2008 Dec; 56(6):434-40. PubMed ID: 19010627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expected years of life lost for six potentially preventable cancers in the United States.
    Liu PH; Wang JD; Keating NL
    Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer screening estimates for U.S. metropolitan areas.
    Nelson DE; Bolen J; Marcus S; Wells HE; Meissner H
    Am J Prev Med; 2003 May; 24(4):301-9. PubMed ID: 12726867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When should we stop screening?
    Rich JS; Black WC
    Eff Clin Pract; 2000; 3(2):78-84. PubMed ID: 10915327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening of cancer of the most frequent localizations].
    Belialova NS; Belialov FI
    Klin Med (Mosk); 2005; 83(10):4-9. PubMed ID: 16320836
    [No Abstract]   [Full Text] [Related]  

  • 18. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.
    Rutter CM; Kim JJ; Meester RGS; Sprague BL; Burger EA; Zauber AG; Ergun MA; Campos NG; Doubeni CA; Trentham-Dietz A; Sy S; Alagoz O; Stout N; Lansdorp-Vogelaar I; Corley DA; Tosteson ANA
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):158-164. PubMed ID: 29150480
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a combined screening programme for breast, cervical and colorectal cancers in France.
    Billette de Villemeur A; Exbrayat C; Garnier A; Ancelle-Park R; Ferley JP; Jestin C
    Eur J Cancer Prev; 2007 Feb; 16(1):26-35. PubMed ID: 17220701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.